Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2009; 15(28): 3523-3527
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3523
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3523
Table 1 Patients’ characteristics
| Age ± SD (yr) | 63.1 ± 10.3 |
| Male:Female | 15:5 |
| Prior surgery (n) | |
| Total gastrectomy with esophagojejunostomy (10) | Covered stent (6) |
| Uncovered stent (4) | |
| Subtotal gastrectomy with Billroth-I reconstruction (2) | Covered stent (1) |
| Uncovered stent (1) | |
| Subtotal gastrectomy with Billroth-II reconstruction (8) | Covered stent (6) |
| Uncovered stent (2) | |
| Chemotherapy after stent insertion (number of patients) | 10 |
| Follow-up loss (n, %) | 3 (15%) |
| 30-d mortality | 3/17 (18%) |
| Survival [median (range)] | 83 (12-439) d |
| Stent patency duration [median (range)] | 56 (5-439) d |
- Citation: Cho YK, Kim SW, Nam KW, Chang JH, Park JM, Jeong JJ, Lee IS, Choi MG, Chung IS. Clinical outcomes of self-expandable metal stents in palliation of malignant anastomotic strictures caused by recurrent gastric cancer. World J Gastroenterol 2009; 15(28): 3523-3527
- URL: https://www.wjgnet.com/1007-9327/full/v15/i28/3523.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3523